Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Studies of Sitagliptin

In clinical studies sitagliptin showed a dose-dependent increase in plasma DPP-4 inhibition with greater than 80% inhibition for 24 h achieved at doses 100 mg [Pg.106]

Dizzier, K. Lasseter, K. Gottesdiener, J. A. Wagner and G. A. Herman, Drug Metab. Dispos., 2007, 35, 533. [Pg.109]

Schrodter, B. Keymeulen, K. C. Lasseter, M. S. Kipnes, K. Snyder, D. Hilliard, M. Tanen, [Pg.109]

See other pages where Studies of Sitagliptin is mentioned: [Pg.95] [Pg.106]